Illumina has entered into a definitive agreement with Standard BioTools under which the company will acquire SomaLogic.

LuxScan 10K Microarray Scanner is a compact high performance system for microarray imaging and data analysis of DNA, protein and cell arrays. Its advanced systems for optics, signal processing and ...

Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions.

June 28, 2025: With this update, we added the Canon imageFormula DR-S350NW, replacing the Canon ImageFormula RS40 as our top pick for Best High-Speed Snapshot and Document Scanner. Since our last ...

Scan-and-go is something that Costco fans on social media have long said they wanted the retailer to bring to its stores, with some noting Walmart-owned competitor Sam’s Club offers it.

Costco is now testing a new “scan-and-go” checkout option aimed at reducing long lines and streamlining the in-store shopping experience for customers, according to Food & Wine Magazine.

Illumina chief executive Francis deSouza confirmed in a LinkedIn post today that he has handed in his resignation, ending a seven-year stint at the helm of the gene-sequencing gia ...

Illumina has been fined €432 million – the maximum amount possible – with a negligible €1,000 penalty also applied to Grail.

The technology is hoped to potentially improve treatment and quality of life for patients, by investigating a new way to scan glioblastoma brain tumours - the most common and aggressive type, with ...

Figure 1: Principle of light up-conversion and experimental setup. Figure 4: cDNA microarray hybridized with biotinylated cDNA derived from a bladder carcinoma 5637 cell line, visualized using ...

QR codes are those square barcode-looking things that when scanned by your iPhone 16 Pro, Galaxy S25 Ultra or any other phone, can send you straight to a particular webpage or to download an app ...

Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies Illumina Inc. (NASDAQ: ILMN) today announced an expanded clinical oncology portfolio, ...